These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 26426264

  • 1. A Quinoline Carboxamide Antimalarial Drug Candidate Uniquely Targets Plasmodia at Three Stages of the Parasite Life Cycle.
    O'Neill PM, Ward SA.
    Angew Chem Int Ed Engl; 2015 Nov 09; 54(46):13504-6. PubMed ID: 26426264
    [No Abstract] [Full Text] [Related]

  • 2. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
    Singh A, Kalamuddin M, Maqbool M, Mohmmed A, Malhotra P, Hoda N.
    Bioorg Chem; 2021 Mar 09; 108():104514. PubMed ID: 33280833
    [Abstract] [Full Text] [Related]

  • 3. Quinoline hybrids and their antiplasmodial and antimalarial activities.
    Hu YQ, Gao C, Zhang S, Xu L, Xu Z, Feng LS, Wu X, Zhao F.
    Eur J Med Chem; 2017 Oct 20; 139():22-47. PubMed ID: 28800458
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of some indolo[3,2-c]quinolines with antimalarial activity.
    Go M, Ngiam T, Tan AL, Kuaha K, Wilairat P.
    Eur J Pharm Sci; 1998 Jan 20; 6(1):19-26. PubMed ID: 16256704
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
    Kumar R, Sharma R, Kumar I, Upadhyay P, Dhiman AK, Kumar R, Kumar R, Purohit R, Sahal D, Sharma U.
    Med Chem; 2019 Jan 20; 15(7):790-800. PubMed ID: 30324888
    [Abstract] [Full Text] [Related]

  • 6. New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents.
    Radini IA, Elsheikh TM, El-Telbani EM, Khidre RE.
    Molecules; 2016 Jul 14; 21(7):. PubMed ID: 27428939
    [Abstract] [Full Text] [Related]

  • 7. Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application.
    Joshi MC, Egan TJ.
    Curr Top Med Chem; 2020 Jul 14; 20(8):617-697. PubMed ID: 31985377
    [Abstract] [Full Text] [Related]

  • 8. Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions.
    Huang G, Solano CM, Melendez J, Yu-Alfonzo S, Boonhok R, Min H, Miao J, Chakrabarti D, Yuan Y.
    Eur J Med Chem; 2021 Jan 01; 209():112889. PubMed ID: 33045660
    [Abstract] [Full Text] [Related]

  • 9. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
    Kalita J, Chetia D, Rudrapal M.
    Med Chem; 2020 Jan 01; 16(7):928-937. PubMed ID: 31385774
    [Abstract] [Full Text] [Related]

  • 10. In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development.
    Fröhlich T, Tsogoeva SB.
    J Med Chem; 2016 Nov 10; 59(21):9668-9671. PubMed ID: 27775354
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New derivatives of quinoline-4-carboxylic acid with antiplasmodial activity.
    Hochegger P, Faist J, Seebacher W, Saf R, Mäser P, Kaiser M, Weis R.
    Bioorg Med Chem; 2017 Apr 01; 25(7):2251-2259. PubMed ID: 28279559
    [Abstract] [Full Text] [Related]

  • 13. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
    Roberts BF, Zheng Y, Cleaveleand J, Lee S, Lee E, Ayong L, Yuan Y, Chakrabarti D.
    Int J Parasitol Drugs Drug Resist; 2017 Apr 01; 7(1):120-129. PubMed ID: 28285258
    [Abstract] [Full Text] [Related]

  • 14. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
    Murithi JM, Owen ES, Istvan ES, Lee MCS, Ottilie S, Chibale K, Goldberg DE, Winzeler EA, Llinás M, Fidock DA, Vanaerschot M.
    Cell Chem Biol; 2020 Feb 20; 27(2):158-171.e3. PubMed ID: 31813848
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
    Mwande Maguene G, Lekana-Douki JB, Mouray E, Bousquet T, Grellier P, Pellegrini S, Toure Ndouo FS, Lebibi J, Pélinski L.
    Eur J Med Chem; 2015 Jan 27; 90():519-25. PubMed ID: 25486423
    [Abstract] [Full Text] [Related]

  • 16. Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.
    Baragaña B, Norcross NR, Wilson C, Porzelle A, Hallyburton I, Grimaldi R, Osuna-Cabello M, Norval S, Riley J, Stojanovski L, Simeons FR, Wyatt PG, Delves MJ, Meister S, Duffy S, Avery VM, Winzeler EA, Sinden RE, Wittlin S, Frearson JA, Gray DW, Fairlamb AH, Waterson D, Campbell SF, Willis P, Read KD, Gilbert IH.
    J Med Chem; 2016 Nov 10; 59(21):9672-9685. PubMed ID: 27631715
    [Abstract] [Full Text] [Related]

  • 17. 2,3,8-Trisubstituted Quinolines with Antimalarial Activity.
    Martinez PDG, Krake SH, Poggi ML, Campbell SF, Willis PA, Dias LC.
    An Acad Bras Cienc; 2018 Nov 10; 90(1 Suppl 2):1215-1231. PubMed ID: 29791525
    [Abstract] [Full Text] [Related]

  • 18. From crystal to compound: structure-based antimalarial drug discovery.
    Drinkwater N, McGowan S.
    Biochem J; 2014 Aug 01; 461(3):349-69. PubMed ID: 25008945
    [Abstract] [Full Text] [Related]

  • 19. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
    Altenkämper M, Bechem B, Perruchon J, Heinrich S, Mädel A, Ortmann R, Dahse HM, Freunscht E, Wang Y, Rath J, Stich A, Hitzler M, Chiba P, Lanzer M, Schlitzer M.
    Bioorg Med Chem; 2009 Nov 15; 17(22):7690-7. PubMed ID: 19819706
    [Abstract] [Full Text] [Related]

  • 20. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S, D'hooghe M.
    Bioorg Med Chem; 2015 Aug 15; 23(16):5098-119. PubMed ID: 25593097
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.